Treatment of Clostridium difficile infection in a French university hospital

References

• Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334–9.
   PubMed Web of Science ®Google Scholar
• Kim J, Kang JO, Kim H, Seo MR, Choi TY, Pai H, et al. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea. Clin Microbiol Infect 2013;19:521–7.
   PubMed Web of Science ®Google Scholar
• Muto CA, Blank MK, Marsh JW, Vergis EN, O’Leary MM, Shutt KA, et al. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin Infect Dis 2007;45:1266–73.
   PubMed Web of Science ®Google Scholar
• Institut de Veille Sanitaire. Conduite à tenir: diagnostic, investigation, surveillance, et principes de prévention et de maîtrise des infections à Clostridium difficile. Available from http://www.invs.sante.fr/publications/2006/guide_raisin/index.html.2006.
   Google Scholar
• Bauer MP, Kuijper EJ, van Dissel JT. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009;15:1067–79.
   PubMed Web of Science ®Google Scholar
• Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431–55.
   PubMed Web of Science ®Google Scholar
• Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 2013;108:478–98.
   PubMed Web of Science ®Google Scholar
• Debast SB, Bauer MP, Kuijper EJ, et al. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014;20:1–26.
   PubMed Web of Science ®Google Scholar
• Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007;45:302–7.
   PubMed Web of Science ®Google Scholar
• Drekonja DM, Amundson WH, Decarolis DD, Kuskowski MA, Lederle FA, Johnson JR. Antimicrobial use and risk for recurrent Clostridium difficile infection. Am J Med 2011;124:1081 e1–7.
   PubMed Web of Science ®Google Scholar
• Harpe SE, Inocencio TJ, Pakyz AL, Oinonen MJ, Polk RE. Characterization of continued antibacterial therapy after diagnosis of hospital-onset clostridium difficile infection: implications for antimicrobial stewardship. Pharmacotherapy 2012;32:744–54.
   PubMed Web of Science ®Google Scholar
• Pop-Vicas A, Shaban E, Letourneau C, Pechie A. Empirical antimicrobial prescriptions in patients with Clostridium difficile infection at hospital admission and impact on clinical outcome. Infect Control Hosp Epidemiol 2012;33:1101–6.
   PubMed Web of Science ®Google Scholar
• Clutter DS, Dubrovskaya Y, Merl MY, Teperman L, Press R, Safdar A. Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea. Antimicrob Agents Chemother 2013;57:4501–5.
   PubMed Web of Science ®Google Scholar
• Nelson RL, Kelsey P, Leeman H, Meardon N, Patel H, Paul K, et al. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults. Cochrane Database Syst Rev 2011:CD004610.
   PubMed Web of Science ®Google Scholar
• Barbut F, Gariazzo B, Bonneé L, Lalande V, Burghoffer B, Luiiz R, et al. Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect Control Hosp Epidemiol 2007;28:131–9.
   PubMed Web of Science ®Google Scholar
• Gerding DN, Muto CA, Owens RCJr. Measures to control and prevent Clostridium difficile infection. Clin Infect Dis 2008;46:S43–9.
   PubMed Web of Science ®Google Scholar
• Owens RC. Clostridium difficile-associated disease: an emerging threat to patient safety: insights from the society of infectious diseases pharmacists. Pharmacotherapy 2006;26:299–311.
   PubMed Web of Science ®Google Scholar
• McFarland LV. Alternative treatments for Clostridium difficile disease: what really works? J Med Microbiol 2005;54:101–11.
   PubMed Web of Science ®Google Scholar
• Guerrero DM, Nerandzic MM, Jury LA, Chang S, Jump RL, Donskey CJ. Clostridium difficile infection in a Department of Veterans Affairs long-term care facility. Infect Control Hosp Epidemiol 2011;32:513–15.
   PubMed Web of Science ®Google Scholar
• Scheurer D. Diagnostic and treatment delays in recurrent Clostridium difficile-associated disease. J Hosp Med 2008;3:156–9.
   PubMed Web of Science ®Google Scholar
• Frenz MB, McIntyre AS. Reducing delays in the diagnosis and treatment of Clostridium difficile diarrhoea. QJM 2003;96:579–82.
   PubMed Web of Science ®Google Scholar
• Johnson S, Louie TJ, Gerding DN, Cornely OA, Chasan-Taber S, Fitts D, et al. Vancomycin, metronidazole, or tolevamer for Clostridium difficile infection: results from two multinational, randomized, controlled trials. Clin Infect Dis 2014;59:345–54.
   PubMed Web of Science ®Google Scholar
• Drekonja DM, Butler M, MacDonald R, Bliss D, Filice GA, Rector TS, et al. Comparative effectiveness of Clostridium difficile treatments: a systematic review. Ann Intern Med 2011;155:839–47.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Crook DW, Esposito R, Poirier A, Somero MS, Weiss K, et al. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis 2012;12:281–9.
   PubMed Web of Science ®Google Scholar
• Aslam S, Hamill RJ, Musher DM. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis 2005;5:549–57.
   PubMed Web of Science ®Google Scholar
• Baines SD, O’Connor R, Freeman J, Fawley WN, Harmanus C, Mastrantonio P, et al. Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother 2008;62:1046–52.
   PubMed Web of Science ®Google Scholar
• Tenover FC, Akerlund T, Gerding DN, Goering RV, Boström T, Jonsson AM, et al. Comparison of strain typing results for Clostridium difficile isolates from North America. J Clin Microbiol 2012;49:1831–7.
   Web of Science ®Google Scholar
• Koo HL, Koo DC, Musher DM, DuPont HL. Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis 2009;48:598–605.
   PubMed Web of Science ®Google Scholar
• van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal EG, de Vos WM, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368:407–15.
   PubMed Web of Science ®Google Scholar
• Navaneethan U, Schauer D, Giannella R. Awareness about Clostridium difficile infection among internal medicine residents in the United States. Minerva Gastroenterol Dietol 2013;57:231–40.
   Google Scholar
• Fayerberg E, Bouchard J, Kellie SM. Knowledge, attitudes and practice regarding Clostridium difficile: A survey of physicians in an academic medical center. Am J Infect Control 2013;41:266–9.
   PubMed Web of Science ®Google Scholar
• Shaughnessy MK, Amundson WH, Kuskowski MA, DeCarolis DD, Johnson JR, Drekonja DM. Unnecessary antimicrobial use in patients with current or recent Clostridium difficile infection. Infect Control Hosp Epidemiol 2013;34:109–16.
   PubMed Web of Science ®Google Scholar
• Gomez-Simmonds A, Kubin CJ, Furuya EY. Comparison of 3 severity criteria for Clostridium difficile infection. Infect Control Hosp Epidemiol 2014;35:196–9.
   PubMed Web of Science ®Google Scholar